ThinkSabio

$BMY

$61.70▲ +2.0% YTD

10 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History
News
BMY ▲ +2.0% - Bristol-Myers Squibb Company
CP $61.70▲ +2.0%Oct 29, 2026 · ThinkSabio Blog

$BMY Bristol-Myers Squibb Q3 earnings — EPS $1.35 vs $1.22 est, beat, down 17% YoY — Revenue $13.069B vs $12.73B est, beat, up 7% YoY — EPS down 34% Q…

News
BMY ▼ -0.6% - Bristol-Myers Squibb Company
CP $62.60▲ -0.6%Oct 23, 2026 · ThinkSabio Blog

$BMY - Pathos AI Secures $237 Million in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline…

News
BMY ▼ -0.7% - Bristol-Myers Squibb Company
CP $62.55▲ -0.7%Oct 23, 2026 · ThinkSabio Blog

$BMY Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Br…

News
BMY ▲ +4.6% - Bristol-Myers Squibb Company
CP $61.89▲ +4.6%Oct 12, 2026 · ThinkSabio Blog

$BMY Bristol Myers Squibb: Phase 3 ALOFT-IPF Trial of Admilparant Meets Primary Endpoint at 60 mg Dose ? • 60 mg twice-daily dose showed a statistical…

News
BMY ▲ +4.6% - Bristol-Myers Squibb Company
CP $61.89▲ +4.6%Oct 12, 2026 · ThinkSabio Blog

$BMY Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint…

News
BMY ▲ +0.2% - Bristol-Myers Squibb Company
CP $59.77▲ +0.2%Oct 8, 2026 · ThinkSabio Blog

$BMY Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-…

News
BMY ▼ -2.1% - Bristol-Myers Squibb Company
CP $62.54▲ -2.1%Sep 29, 2026 · ThinkSabio Blog

$BMY new lows…

News
BMY ▼ -2.1% - Bristol-Myers Squibb Company
CP $62.54▲ -2.1%Sep 29, 2026 · ThinkSabio Blog

$BMY moving down…

News
BMY ▼ -0.9% - Bristol-Myers Squibb Company
CP $66.25▲ -0.9%Sep 8, 2026 · ThinkSabio Blog

$BMY Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-D…

SEC 13D/G
BMY - Bristol-Myers Squibb Company - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified
$64.04▲ 19.75%Aug 7, 2026 · ThinkSabio Blog

$BMY SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #BMY Bristol-Myers Squibb Company : $64.04 Sector: Healthcare | Y…